* Note: Prices are in Million (M) USD.
Description:
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $7 M
Debt : $654 M
EBITDA : $85 M
Net Debt (Debt - Cash): $647 M
Since EBITDA cannot cover net debt within 3 years, Avoid This Stock.
This criteria used industry in which company operates:
Sector: Real Estate
Industry: REIT - Healthcare Facilities
Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 122.17
Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $-91 M
Average Revenue: $61 M
Revenue Converted To Free Cash Flow (%): -150%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 22.94%
Since Free Cash Flow (FCF) to Revenue percentage is non-positive, 0 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $138 M
Revenue 4 Years Ago (2020-12-31): $94 M
Last 5 Years Average Revenue Growth: 10%
Since Revenue Growth is between 5 - 10, 2 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $66 M
Share Count 5 Years Ago (2020-12-31): $46 M
Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $0.09
Trailing 12-Month Earnings Per Share (EPS): $0.03
Average Earnings Per Share (EPS): $0.06
Dividend Per Share (DPS): $1
Payout Ratio: 1400%
Dividend Yield: 12%
Since company Payout Ratio is greater than 50, 1 point assigned.
Since Dividend Yield is greater than 5, 5 points assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -106%
Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $7
52-Week Low: $6
Threshold Price (15% Above 52-Week Low): $7
Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $911 M
Since Market Cap is less than 10B, 1 point assigned.
% Exposure to Total Portfolio
Based on the market cap, we recommend do not exceed 0.20% exposure of Total Portfolio.
Value-Trade has assigned 12 points to above Global Medical REIT Inc (GMRE) stock.
Last 4 Years Avg PE 47.27, Fair Value PE 12, Industry Based PE 20, Growth Based PE 9. Based on these 4 values, average assigned is 22.07.
Value-Trades has assined P/E value 22.07. Since an average (Current Year EPS + Next Year EPS) earning per share is $0.06.
The fair value of Global Medical REIT Inc (GMRE) stock should be (22.07 x $0.06) = $1.32
